Cargando…
Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
Cardiovascular protein therapeutics such as neuregulin (NRG1) and acidic-fibroblast growth factor (FGF1) requires new formulation strategies that allow for sustained bioavailability of the drug in the infarcted myocardium. However, there is no FDA-approved injectable protein delivery platform due to...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868965/ https://www.ncbi.nlm.nih.gov/pubmed/27184924 http://dx.doi.org/10.1038/srep25932 |
_version_ | 1782432237065601024 |
---|---|
author | Garbayo, Elisa Gavira, Juan José de Yebenes, Manuel Garcia Pelacho, Beatriz Abizanda, Gloria Lana, Hugo Blanco-Prieto, María José Prosper, Felipe |
author_facet | Garbayo, Elisa Gavira, Juan José de Yebenes, Manuel Garcia Pelacho, Beatriz Abizanda, Gloria Lana, Hugo Blanco-Prieto, María José Prosper, Felipe |
author_sort | Garbayo, Elisa |
collection | PubMed |
description | Cardiovascular protein therapeutics such as neuregulin (NRG1) and acidic-fibroblast growth factor (FGF1) requires new formulation strategies that allow for sustained bioavailability of the drug in the infarcted myocardium. However, there is no FDA-approved injectable protein delivery platform due to translational concerns about biomaterial administration through cardiac catheters. We therefore sought to evaluate the efficacy of percutaneous intramyocardial injection of poly(lactic-co-glycolic acid) microparticles (MPs) loaded with NRG1 and FGF1 using the NOGA MYOSTAR injection catheter in a porcine model of ischemia-reperfusion. NRG1- and FGF1-loaded MPs were prepared using a multiple emulsion solvent-evaporation technique. Infarcted pigs were treated one week after ischemia-reperfusion with MPs containing NRG1, FGF1 or non-loaded MPs delivered via clinically-translatable percutaneous transendocardial-injection. Three months post-treatment, echocardiography indicated a significant improvement in systolic and diastolic cardiac function. Moreover, improvement in bipolar voltage and decrease in transmural infarct progression was demonstrated by electromechanical NOGA-mapping. Functional benefit was associated with an increase in myocardial vascularization and remodeling. These findings in a large animal model of ischemia-reperfusion demonstrate the feasibility and efficacy of using MPs as a delivery system for growth factors and provide strong evidence to move forward with clinical studies using therapeutic proteins combined with catheter-compatible biomaterials. |
format | Online Article Text |
id | pubmed-4868965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48689652016-05-31 Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion Garbayo, Elisa Gavira, Juan José de Yebenes, Manuel Garcia Pelacho, Beatriz Abizanda, Gloria Lana, Hugo Blanco-Prieto, María José Prosper, Felipe Sci Rep Article Cardiovascular protein therapeutics such as neuregulin (NRG1) and acidic-fibroblast growth factor (FGF1) requires new formulation strategies that allow for sustained bioavailability of the drug in the infarcted myocardium. However, there is no FDA-approved injectable protein delivery platform due to translational concerns about biomaterial administration through cardiac catheters. We therefore sought to evaluate the efficacy of percutaneous intramyocardial injection of poly(lactic-co-glycolic acid) microparticles (MPs) loaded with NRG1 and FGF1 using the NOGA MYOSTAR injection catheter in a porcine model of ischemia-reperfusion. NRG1- and FGF1-loaded MPs were prepared using a multiple emulsion solvent-evaporation technique. Infarcted pigs were treated one week after ischemia-reperfusion with MPs containing NRG1, FGF1 or non-loaded MPs delivered via clinically-translatable percutaneous transendocardial-injection. Three months post-treatment, echocardiography indicated a significant improvement in systolic and diastolic cardiac function. Moreover, improvement in bipolar voltage and decrease in transmural infarct progression was demonstrated by electromechanical NOGA-mapping. Functional benefit was associated with an increase in myocardial vascularization and remodeling. These findings in a large animal model of ischemia-reperfusion demonstrate the feasibility and efficacy of using MPs as a delivery system for growth factors and provide strong evidence to move forward with clinical studies using therapeutic proteins combined with catheter-compatible biomaterials. Nature Publishing Group 2016-05-17 /pmc/articles/PMC4868965/ /pubmed/27184924 http://dx.doi.org/10.1038/srep25932 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Garbayo, Elisa Gavira, Juan José de Yebenes, Manuel Garcia Pelacho, Beatriz Abizanda, Gloria Lana, Hugo Blanco-Prieto, María José Prosper, Felipe Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion |
title | Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion |
title_full | Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion |
title_fullStr | Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion |
title_full_unstemmed | Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion |
title_short | Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion |
title_sort | catheter-based intramyocardial injection of fgf1 or nrg1-loaded mps improves cardiac function in a preclinical model of ischemia-reperfusion |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868965/ https://www.ncbi.nlm.nih.gov/pubmed/27184924 http://dx.doi.org/10.1038/srep25932 |
work_keys_str_mv | AT garbayoelisa catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion AT gavirajuanjose catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion AT deyebenesmanuelgarcia catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion AT pelachobeatriz catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion AT abizandagloria catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion AT lanahugo catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion AT blancoprietomariajose catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion AT prosperfelipe catheterbasedintramyocardialinjectionoffgf1ornrg1loadedmpsimprovescardiacfunctioninapreclinicalmodelofischemiareperfusion |